Financial Results
Since our first sale in 2006, an entrepreneurial spirit and a determination to see possibilities instead of limitations have been the main drivers behind the impressive development of Abacus Medicine.
We have achieved significant organic growth in each year of our existence. But while consistent in delivering results, we have already reinvented the company a number of times in its short history.
We have adapted to market changes and found new business in new markets and new products.
KEY FIGURES IN EUR '000
2020
2019
2018
2017
2016
Revenue
663,501
421,445
332,347
253,056
177,850
Adjusted EBITDA
12,959
14,753
13,645
9,794
6,622
EBITDA
12,483
10,649
12,580
9,417
6,622
Profit for the year
433
829
5,359
4,328
3,259
Equity
53,024
51,616
14,399
9,671
9,406
Total assets
219,527
126,964
97,236
56,507
58,163
REVENUE (EUR million)
178
2016
253
2017
332
2018
421
2019
664
2020
Annual Report 2020
Numbers, earnings and more. How did we progress, and what are our plans?
Previous Annual Reports
Contact
We are happy to help, so please get in touch. Below you will find our main offices, but we have people covering all of Europe.
ABACUS MEDICINE Headquarters
Global Sales, Supply Chain and Finance
Vesterbrogade 149
1620 Copenhagen V
Denmark
ABACUS MEDICINE Austria
Austrian Sales and Customer Support
Wolfgang-Pauli-Gasse 5/1/1/6
A-1140 Wien
Österreich
ABACUS MEDICINE Hungary
Production and Regulatory
Maglódi út 6
1106 Budapest
Hungary
ABACUS MEDICINE Berlin GmbH
German Sales and Customer support
Berliner Straße 8
D-16727 Velten
Deutschland
ABACUS MEDICINE UK
UK Sales and Customer Support
Abbey House
282 Farnborough Road
Farnborough GU14 7NA
England
ABACUS MEDICINE Finland
Finnish Sales and Customer Support
Orionintie 5
02200 Espoo
Finland
ABACUS MEDICINE France
French Sales and Customer Support
12/14 Rond-Point des Champs-Elysées
Paris 75008, France
ABACUS MEDICINE Netherlands
Production and Quality Assurance
Diamantweg 4
1812 RC Alkmaar
Holland
